- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12. | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | ZEO ScientifiX, Inc.: ZEO ScientifiX and Exotropin Join Forces to Launch a Solution to Address the Growing Unmet Need for Hair Loss | 169 | ACCESSWIRE | FORT LAUDERDALE, FL / ACCESSWIRE / November 13, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced it has partnered... ► Artikel lesen | |
| 15.10. | Zeo ScientifiX, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 15.10. | Zeo ScientifiX, Inc.: ZEO ScientifiX, a Leading South Florida Biotechnology Company, Launches Regenerative Medicine Educational Series for Physicians | 179 | ACCESSWIRE | Events Hosted By ZEO ScientifiX Offer Providers Practical Business Tools Along With Science And Research Insights FORT LAUDERDALE, FL / ACCESSWIRE / October 15, 2024 / ZEO ScientifiX, Inc. ("ZEO" or... ► Artikel lesen | |
| 01.10. | Zeo ScientifiX, Inc.: ZEO ScientifiX Partners with National Provider of Healthcare Services | 184 | ACCESSWIRE | Physicians Group, LLC's Network Of Clinics And Diverse Patient Population Will Provide ZEO With Exclusive Research-Based OpportunitiesFORT LAUDERDALE, FL / ACCESSWIRE / October 1, 2024 / ZEO ScientifiX... ► Artikel lesen | |
| 30.09. | Zeo ScientifiX, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ZEO SCIENTIFIX Aktie jetzt für 0€ handeln | |||||
| 24.09. | Zeo ScientifiX, Inc.: ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research | 251 | ACCESSWIRE | South Florida Biotech Company Seeks To Expand Its Research Program Into Phase 2 Clinical TrialsFORT LAUDERDALE, FL / ACCESSWIRE / September 24, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX)... ► Artikel lesen | |
| 20.09. | Zeo ScientifiX, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.09. | Zeo ScientifiX, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.08. | Zeo ScientifiX, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.07. | Zeo ScientifiX, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.03. | Organicell Regenerative Medicine, Inc. Rebranding to ZEO ScientifiX, Inc. | 533 | ACCESSWIRE | Leading Therapeutics Research Company Begins New EraCommon Stock to trade on OTCQB under the symbol "ZEOX" commencing March 5, 2024FORT LAUDERDALE, FL / ACCESSWIRE / March 4, 2024 / ZEO ScientifiX,... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES | 139,03 | 0,00 % | Neurocrine Announces Commercial Launch Of Crenessity In US | WASHINGTON (dpa-AFX) - Neurocrine Biosciences, Inc. (NBIX), Friday announced the commercial launch of Crenessity in the U.S. for adult and pediatric patients with classic congenital adrenal... ► Artikel lesen | |
| AMGEN | 263,24 | -0,47 % | Spotlight on Amgen: Analyzing the Surge in Options Activity | ||
| BIOGEN | 149,90 | 0,00 % | BMO cuts rating on Merck and Biogen, on lack of near term catalyst | ||
| IDEXX LABORATORIES | 417,11 | 0,00 % | Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback? | ||
| REGENERON PHARMACEUTICALS | 716,74 | +0,32 % | Regeneron Pharma: Phase 3 Trial With EYLEA HD 8 Mg Meets Primary Endpoint | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Regeneron Pharmaceuticals (REGN) announced the primary endpoint was met in the Phase 3 QUASAR trial investigating EYLEA HD or aflibercept injection 8 mg... ► Artikel lesen | |
| SAREPTA THERAPEUTICS | 123,37 | +1,21 % | Sarepta awarded $115.2M in Vyondys 53 patent case: report | ||
| MODERNA | 40,440 | 0,00 % | Moderna-Deutschland-Chef im Interview (2): "Onkologie ist ein bedeutendes Forschungsfeld für ... | Die Aktie von Moderna hat sich in den vergangenen Monaten alles andere als erfreulich entwickelt. Im Mai notierte das Papier noch über 170 Dollar. Mittlerweile steht seitdem ein Kursverlust von 77 Prozent... ► Artikel lesen | |
| QUANTUM-SI | 2,150 | 0,00 % | Quantum-Si präsentiert ProteoVue-Software für Proteinforschung | ||
| VAXCYTE | 85,78 | 0,00 % | Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset | ||
| GERON | 3,300 | 0,00 % | Geron Gets Positive CHMP Opinion For RYTELO In Transfusion-Dependent Anemia Due To Lower-Risk MDS | WASHINGTON (dpa-AFX) - Geron Corporation (GERN), a commercial-stage biopharmaceutical company, Friday said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 7,660 | 0,00 % | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 48,030 | +1,03 % | Evotec: COO-Abgang und Halozyme-Übernahmepläne | Dr. Craig Johnstone, COO von Evotec, verlässt das Unternehmen nach zwölf Jahren, während ein internes Team vorübergehend seine Aufgaben übernimmt. Parallel brodelt die Gerüchteküche um eine mögliche... ► Artikel lesen | |
| TEMPUS AI | 35,230 | 0,00 % | Tempus AI (NASDAQ:TEM) Shares Down 5.7% Following Insider Selling | ||
| GUARDANT HEALTH | 31,370 | 0,00 % | Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance | PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2024.
Third Quarter... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 7,600 | 0,00 % | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | SAN CARLOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering... ► Artikel lesen |
ZEO SCIENTIFIX INC gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZEO SCIENTIFIX INC finden Sie auf Wallstreet Online.
